Search hospitals > Pennsylvania > Philadelphia
Fox Chase Cancer Center
Claim this profilePhiladelphia, Pennsylvania 19111
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
1153 reported clinical trials
68 medical researchers
Summary
Fox Chase Cancer Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Parotid Gland Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Fox Chase Cancer Center is involved with conducting 1,153 clinical trials across 674 conditions. There are 68 research doctors associated with this hospital, such as Anthony J. Olszanski, Jessica Bauman, MD, Margaret von Mehren, MD, and Deric C. Savior.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Anthony J. OlszanskiFox Chase Cancer Center4 years of reported clinical research
Expert in Solid Tumors
Studies Melanoma
17 reported clinical trials
24 drugs studied
Jessica Bauman, MDFox Chase Cancer Center4 years of reported clinical research
Studies Lung Cancer
Studies Solid Tumors
12 reported clinical trials
25 drugs studied
Margaret von Mehren, MDFox Chase Cancer Center4 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Liposarcoma
12 reported clinical trials
45 drugs studied
Deric C. SaviorPaoli Memorial Hospital10 years of reported clinical research
Studies Parotid Gland Cancer
Studies Lung Cancer
11 reported clinical trials
27 drugs studied
Clinical Trials running at Fox Chase Cancer Center
Breast Cancer
Cancer
Lung Cancer
Parotid Gland Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Solid Tumors
Melanoma
Multiple Myeloma
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Fox Chase Cancer Center?
Where is Fox Chase Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Fox Chase Cancer Center accept?
What awards or recognition has Fox Chase Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.